Document Detail


Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents.
MedLine Citation:
PMID:  11360154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In vitro studies have shown that acylation stimulating protein (ASP) stimulates triglyceride (TG) synthesis and storage in adipocytes. We have previously demonstrated that intraperitoneal (i.p.) injection of ASP in C57BL/6J mice accelerated TG clearance following an orally-administered fat load as well as reducing postprandial glucose levels.
RESULTS: In the present study, we first examined the effect of i.p. and intracerebroventricular (i.c.v.) injection of ASP on food intake in Sprague-Dawley rats. Intraperitoneal injection resulted in a short-term increase in food intake (maximum increase 29.3% within the first hour, P<0.025) decreasing thereafter as compared to vehicle alone. i.c.v. Administration of a comparable dose of ASP resulted in a similar but delayed increase in food intake with a maximum at 2-4 h, suggesting that the actions of ASP are peripherally mediated. However, there was no significant difference in 24 h food intake with either i.p. or i.c.v. injection. We also examined the effects of ASP on TG clearance in two obese mouse strains with different metabolic profiles: ob/ob (C57BL/6J-Lep(ob)) and db/db (C57BLKS/J-Lepr(db)). In a crossover design, the response to an oral fat load was determined with and without i.p. injection of exogenous ASP. In ob/ob mice, there was a 44% greater clearance of postprandial TG (area under the curve (AUC)=245+/-49 control vs 138+/-43 mg/dl h with ASP; P<0.05 by RM ANOVA). The db/db mice showed a greater response, with a 62% decrease in postprandial TG (AUC=4080+/-1489 control vs 1540+/-719 mg/dl h with ASP; P=0.004 by RM ANOVA). In addition there were decreases in postprandial glucose and non-esterified fatty acid (NEFA) levels in response to ASP.
CONCLUSION: These results are the first to report that ASP can increase food intake in rats and also enhance postprandial TG clearance in obese animals. These data therefore support previous in vitro evidence pointing to ASP as a regulator of lipid metabolism.
Authors:
J Saleh; J E Blevins; P J Havel; J A Barrett; D W Gietzen; K Cianflone
Related Documents :
12376184 - Down-regulation of cannabinoid-1 (cb-1) receptors in specific extrahypothalamic regions...
12907414 - Effects of the opioid antagonist naltrexone on feeding induced by damgo in the ventral ...
2189144 - Enantiomers of phenylpropanolamine suppress food intake in hyperphagic rats.
1475284 - Effects of methadone on free feeding in satiated rats.
23698054 - Impact of fruit piece structure in yogurts on the dynamics of aroma release and sensory...
24105414 - The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in th...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity     Volume:  25     ISSN:  -     ISO Abbreviation:  Int. J. Obes. Relat. Metab. Disord.     Publication Date:  2001 May 
Date Detail:
Created Date:  2001-05-21     Completed Date:  2001-12-14     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  9313169     Medline TA:  Int J Obes Relat Metab Disord     Country:  England    
Other Details:
Languages:  eng     Pagination:  705-13     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Area Under Curve
Blood Proteins / administration & dosage,  pharmacology*
Complement C3a* / analogs & derivatives*
Cross-Over Studies
Eating / drug effects*
Injections, Intraperitoneal
Injections, Intraventricular
Lipids / blood*
Male
Mice
Mice, Inbred C57BL
Postprandial Period*
Rats
Rats, Sprague-Dawley
Time Factors
Triglycerides / biosynthesis,  pharmacokinetics
Grant Support
ID/Acronym/Agency:
DK07355/DK/NIDDK NIH HHS; DK35747/DK/NIDDK NIH HHS; DK50129/DK/NIDDK NIH HHS; NS33347/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Blood Proteins; 0/Lipids; 0/Triglycerides; 0/complement C3a, des-Arg-(77)-; 80295-42-7/Complement C3a

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of cir...
Next Document:  Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and o...